AD/ADRD Clinical Trials Short Course

The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to invite applications for the development of creative and innovative short courses to train the next generation of AD/ADRD clinical trialists in state-of-the-art clinical research skills. This opportunity aims to expand the skilled Alzheimer's disease (AD) and AD-related dementias (ADRD) clinical trial workforce. The scope of work includes developing interventions to treat and prevent dementia, provide dementia care, and promote the health and well-being of dementia caregivers. Key aspects of this opportunity include: • The development of short courses to train AD/ADRD clinical trialists • The focus on state-of-the-art clinical research skills • The goal of expanding the skilled AD/ADRD clinical trial workforce • The inclusion of various types of dementia, such as frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), and mixed dementia • The importance of developing meaningful collaborations and responsive projects